Brenda Cartmel
Overview
Explore the profile of Brenda Cartmel including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
86
Citations
1383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
31.
Meyerhardt J, Irwin M, Jones L, Zhang S, Campbell N, Brown J, et al.
JNCI Cancer Spectr
. 2020 Feb;
4(1):pkz096.
PMID: 32090192
Background: Observational data support inverse relationships between exercise or metformin use and disease outcomes in colorectal and breast cancer survivors, although the mechanisms underlying these associations are not well understood....
32.
Usiskin I, Li F, Irwin M, Cartmel B, Sanft T
Breast Cancer
. 2019 May;
26(6):719-728.
PMID: 31119682
Purpose: Physical activity and lower BMI have shown benefit for breast cancer survival, but the association between these factors, pathologic complete response (pCR), and chemotherapy completion is not clear. We...
33.
Baglia M, Lin I, Cartmel B, Sanft T, Ligibel J, Hershman D, et al.
Cancer
. 2019 Mar;
125(13):2262-2271.
PMID: 30840336
Background: The objective of this study was to evaluate the role of a 12-month exercise intervention on endocrine-related quality of life (QOL) and overall QOL among breast cancer survivors with...
34.
Layne T, Ferrucci L, Jones B, Smith T, Gonsalves L, Cartmel B
Cancer Causes Control
. 2018 Nov;
30(1):21-29.
PMID: 30392148
Purpose: To examine the concordance between cancer registry and self-reported data for race, Hispanic ethnicity, and cancer type in the American Cancer Society's Studies of Cancer Survivors (SCS) I and...
35.
Sanft T, Usiskin I, Harrigan M, Cartmel B, Lu L, Li F, et al.
Breast Cancer Res Treat
. 2018 Aug;
172(1):105-112.
PMID: 30062572
Purpose: Some studies suggest that telomere shortening may be associated with increased breast cancer risk and mortality. Obesity is also associated with increased breast cancer risk and mortality. Few studies...
36.
Zhou Y, Cartmel B, Gottlieb L, Ercolano E, Li F, Harrigan M, et al.
J Natl Cancer Inst
. 2018 Jul;
109(12).
PMID: 30053074
Background: Ovarian cancer survivors experience a wide range of treatment side effects that can negatively affect health-related quality of life (HRQOL). Physical activity has been shown to improve HRQOL and...
37.
Viola A, Mitchell H, Salner A, Gillan E, Rotatori J, Cartmel B, et al.
Clin J Oncol Nurs
. 2018 Apr;
21(3):E71-E78.
PMID: 29658261
Background: Adolescents and young adults (AYAs) face increased risk for physical, social, and cognitive late complications of cancer therapy. Strategies are needed to better engage AYAs in survivorship research. Objectives:...
38.
Adams B, Arem H, Hubal M, Cartmel B, Li F, Harrigan M, et al.
Breast Cancer Res Treat
. 2018 Mar;
170(1):55-67.
PMID: 29511965
Purpose: Obesity and weight gain are associated with comorbidities including a higher risk of tumor recurrence and cancer-related deaths among breast cancer (BC) survivors; however, the underlying mechanisms linking obesity...
39.
Iyer N, Cartmel B, Friedman L, Li F, Zhou Y, Ercolano E, et al.
Cancer
. 2018 Feb;
124(9):1929-1937.
PMID: 29437202
Background: Lymphedema is a poorly understood side effect of gynecologic cancer treatment. This study was designed to determine the prevalence of lower limb lymphedema (LLL) in a sample of ovarian...
40.
Ferrucci L, Cartmel B, Clare R, Choy C, Kershaw T, Leffell D, et al.
J Am Acad Dermatol
. 2018 Jan;
79(1):149-152.
PMID: 29291957
No abstract available.